Lisle, Il., January 30, 2025 — Anju Software, a prominent provider of software solutions for the life sciences industry, is thrilled to announce its participation in the 16th annual SCOPE Summit for Clinical Ops Executives from February 3-6, 2025, in Orlando, Florida.
In the classic tale of the three little pigs, only one house withstood the relentless attack of the big bad wolf. Why? It was built on a strong foundation—strategically planned and carefully executed. When it comes to clinical trials, the same principle applies. Trials built on shaky foundations, like straw or sticks, risk falling apart when faced with operational and recruitment challenges. But those constructed with data-driven insights, robust planning, and expert strategies? They endure.
The stakes for clinical trial feasibility have never been higher. With increasingly granular patient sub-populations and rising global competition, designing a trial that succeeds requires more than just access to data. It demands blending clinical intelligence with operational expertise to create a solid, resilient structure that can withstand even the toughest challenges—the unexpected “wolves” that can derail success.
The Foundation of Success: Feasibility and Precision
Clinical feasibility has evolved dramatically in recent years. Tools like TA Scan Feasibility now provide access to powerful data and intelligence, enabling sponsors and CROs to plan with unparalleled precision. But even the best tools need expert guidance. Trials that thrive combine predictive analytics, real-world clinical expertise, and forward-thinking strategies.
So, how can you ensure your trial is built to last? It starts with the right blueprint:
- Enrollment Modeling: Predicting patient recruitment accurately is no longer a luxury; it’s a necessity. With advanced modeling tools, you can reduce uncertainty and ensure enrollment goals are met.
- Site Selection: Choosing the right sites goes beyond historical performance. You need to prioritize those with capacity, experience, and alignment with your trial’s specific needs.
- Risk Mitigation: Unforeseen challenges are inevitable, but how you prepare for them defines success. Integrating risk strategies into your trial planning ensures you’re ready for anything.
A Strategic Approach: Insights from the Experts
Anju Software is bringing these strategies to life at SCOPE and in an upcoming webinar, “The Three Little Pigs’ Tale – A Strategic Approach to Clinical Trial Feasibility.” Featuring insights from clinical trial experts Barbara Argibay and Elke Ydens, this interactive session will explore actionable approaches to enrollment, site selection, and risk mitigation.
Here’s why you’ll want to attend:
- Learn to Build with Bricks: Discover how to leverage clinical intelligence alongside operational insights for precise trial planning.
- Strengthen Your Foundation: Gain strategies for identifying and optimizing site selection to meet your unique trial needs.
- Plan for the Wolves: Explore how risk mitigation and data-driven tools can protect your trial from unexpected challenges.
Trials That Endure
Whether you’re a seasoned clinical operations professional or new to feasibility planning, the takeaway is clear: trials succeed when they’re built on a foundation of robust data and thoughtful strategy.
Don’t let your trial crumble like straw or sticks. Join Anju at Booth 1016 at SCOPE or watch for the webinar, and learn how to build it with bricks—strong, smart, and designed to last.
About Anju Software
Anju Software is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company’s flagship products, lead the way in reducing complexities in the drug and device discovery and commercialization process. Anju is a portfolio company of Valsoft Corporation serving the worldwide pharmaceutical, biotech and contract research Life Sciences markets.